Swiss Pharmaceuticals 5-Amino-1MQ 60 kaps.

Description

Swiss Pharmaceuticals 5-Amino-1MQ 60 kaps

What is 5-amino-1MQ?

5-amino-1MQ is a small-molecule drug that works by blocking the activity of an enzyme called nicotinamide N-methyltransferase (NNMT). NNMT plays an important role in metabolism and energy production and is primarily active in adipose tissue. By blocking NNMT, 5-amino-1MQ causes an increase in nicotinamide adenine dinucleotide (NAD+), a cofactor at the center of cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1). SIRT1 is also known as the “longevity gene” due to its role in reducing the risk of diabetes, obesity, metabolic syndrome, atherosclerosis and other cardiovascular diseases, kidney disease, liver disease, neurodegeneration, and cancer.

Simply put

This means that 5-amino-1MQ enables your body to burn fat for energy while prioritizing the preservation of muscle mass. 5-amino-1MQ is safe and effective for reversing and preventing diet-induced obesity. It is potentially a better treatment option for individuals with (or at risk of) type 2 diabetes and other metabolic comorbidities associated with obesity. Additionally, the activation of SIRT1 via increased NAD+ suggests that 5-amino-1MQ is a good choice for patients seeking to develop a comprehensive anti-aging protocol.
Obesity, osteoarthritis, cardiovascular diseases, cancer, Parkinson’s disease, kidney diseases, metabolic disorders, and other related chronic metabolic comorbidities.

Nicotinamide N-methyltransferase (NNMT) is a cytoplasmic enzyme that has recently been identified as playing a role in cellular metabolism and energy homeostasis. Studies show that this enzyme slows down the process by which our bodies metabolize fat cells. Most people struggle to lose weight, and when levels of this enzyme are high, it becomes even more difficult to shed excess fat. Being overweight leads to an increase in the NNMT enzyme, which slows down fat metabolism and causes excessive weight gain. This is a vicious cycle. Research shows that “5-amino-1mq,” a potent NNMT inhibitor, significantly reduces body weight and white fat mass, shrinks fat cell size, and lowers total plasma cholesterol levels.

These findings support the therapeutic development of small-molecule NNMT inhibitors to reverse diet-induced obesity and confirm NNMT as a suitable target for the treatment of obesity and related metabolic disorders.

Benefits:

NNMT inhibitors as a treatment to reverse diet-induced obesity.

NNMT is a valid target for the treatment of obesity and related metabolic diseases.

It prevents fat formation and reverses diet-induced obesity. NNMT expression increases in white adipose tissue (WAT). Brown adipose tissue has significantly higher activity in WAT compared to its activity in the liver and lungs.